ArticleCureus2025
Breaking the Silence: A Case for Early Intervention in Profound Adolescent Hearing Loss.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progressive unilateral hearing loss (PUHL) in adolescents is uncommon and presents diagnostic challenges due to its varied etiologies, including infections, ototoxicity, congenital anomalies, and autoimmune conditions, though many cases remain idiopathic. We report a 16-year-old male with a history of COVID-19, dengue at age 14, and recurrent headaches, who developed left-sided hearing loss progressing to profound unilateral deafness. Audiometry confirmed sensorineural hearing loss (SNHL) of 97 dB HL in the left ear and 35 dB HL in the right. Despite multiple evaluations, no definitive etiology was identified. Differential diagnoses included post-viral sequelae, congenital anomalies (e.g., Mondini dysplasia), and nasal obstruction, though insurance limitations restricted further testing. The patient discontinued hearing aid use due to limited benefit and experienced social withdrawal, impacting both academic performance and overall well-being. This case underscores the importance of early recognition and a systematic, multidisciplinary approach to PUHL, including imaging and genetic testing, given its potential impact on social development, mental health, and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.